secwatch / observer
8-K filed October 20, 2023, 7:59 PM ET ticker TLPH CIK 0001427925
regulatory confidence high sentiment negative materiality 0.75

TALPHERA, INC. (TLPH): Nasdaq/NYSE listing notice — AcelRx receives Nasdaq non-compliance notice for bid price below $1.00

TALPHERA, INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 1.0

TALPHERA, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
minimum bid price
Rules
5450(a)(1)
Exact text from the filing
October 18, 2023, AcelRx Pharmaceuticals, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecu
View on SEC.gov

Browse all listing & compliance notices →

TALPHERA, INC. filing history →

Source: SEC EDGAR
accession 0001437749-23-028683
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.